WebJan 23, 2024 · BioCentury's streaming commentary on biotech industry trends, plus interviews with leading KOLs. For over 28 years, BioCentury has given biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; industry-leading business … WebBioCentury's Distillery Dashboard is a searchable database summarizing translational papers from over 25 top journals, with new innovations added continuously. Search for … See the global pipeline against the indication of interest. Filter by … How to reach BioCentury by email and phone. Subscription inquiries. Trial … BioCentury's Analysts & Research Team is comprised of industry-recognized … BioCentury's Management Team includes executives with backgrounds in the … Trial Our Platform - BioCentury - Home For a decade, BioCentury and BayHelix and our partners have brought together a … Log In - BioCentury - Home Sponsoring or advertising with BioCentury is a perfect way to communicate your … Customer Resource Center - BioCentury - Home Forgot Password - BioCentury - Home
A Cancer Target Revolution Revolution Medicines
WebBioCentury and BayHelix Present: The 5th China Healthcare Summit - China's Globally Facing Future. The China Summit is a VIP-only event for busy biopharma and life … WebSep 8, 2015 · BioCentury Publications Inc. today announced that Karen Bernstein, Ph.D., has stepped down as Editor-in-Chief to devote full time to corporate development as Chairman of the company she co-founded ... greenwood airvac extractor fan instructions
NPC in the News National Pharmaceutical Council
WebIn this section, you can unsubscribe from emails associated with a paid subscription. By doing this, you will no longer receive emails informing you of new articles and editions. ... Unsubscribe me from BioCentury emails delivered weekly and BioCentury Distillery emails delivered monthly. You will still have access to articles and editions ... WebDec 21, 2024 · Appointments and advancements (BioWorld, Subscription Required) ... Greene becomes chief investment officer at Hevolution, and updates from Aerami and Curate (BioCentury, Subscription Required) Aug 18, 2024. Aerami KOL Call: Inhaled Imatinib (AER-901) for the Treatment of Pulmonary Arterial Hypertension (LifeSci … WebApr 30, 2024 · When McKinsey and BioCentury interviewed representatives from 106 biotech companies in May 2024, 4 See “COVID-19: Reimagining biotech in 2024,” webinar, BioCentury, July 8, 2024, biocentury.com. half of those interviewed were expecting delays in financing, and about 80 percent were tight on cash for the next two years and … greenwood airvac extractor fan rf90tw